[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363410-105":59,"doc-detail-363410-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nanotechnology-in-cancer-therapy-how-nanoparticles-are-shaping-the-future-of-personalized-treatment","Nanotechnology in Cancer Therapy - How Nanoparticles Are Shaping the Future of Personalized Treatment","","Nanotechnology has transformed cancer research by establishing nanoparticles as versatile platforms for therapy and diagnosis, leveraging tunable physicochemical properties and biocompatibility. Nanoparticles support targeted drug delivery, enhanced pharmacokinetics, and reduced systemic toxicity versus conventional treatments, while also enabling molecular imaging and theragnostic strategies. Over eight FDA/EMA-approved nanoparticle formulations demonstrate clinical relevance. Translation is constrained by biological and technical barriers, including EPR variability, limited tumor penetration, and manufacturing scalability. This review synthesizes preclinical and translational progress with selected clinical examples.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nanotechnology-in-cancer-therapy-how-nanoparticles-are-shaping-the-future-of-personalized-treatment/363410/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nanotechnology-in-cancer-therapy-how-nanoparticles-are-shaping-the-future-of-personalized-treatment/363410.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What advantages do nanoparticles provide for cancer therapy and diagnosis?","Question",{"text":112,"@type":113},"Nanoparticles offer tunable physicochemical properties and biocompatibility, enabling targeted drug delivery, better pharmacokinetics, and reduced systemic toxicity. They also support molecular imaging and theragnostic applications such as imaging-guided therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is clinical translation of nanomedicine still limited?",{"text":117,"@type":113},"Clinical translation is constrained by biological and technical challenges including variability in the enhanced permeability and retention (EPR) effect, insufficient tumor penetration, and low manufacturing scalability.",{"name":119,"@type":110,"acceptedAnswer":120},"How does this review structure its discussion of nanoparticle approaches?",{"text":121,"@type":113},"The review emphasizes preclinical and translational nanomedicine with selected clinical examples. It summarizes progress across major nanocarrier classes, including liposomes and polymeric, inorganic, and hybrid nanoparticles, and discusses their roles in cancer therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363410,1790178261,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/ACSNanoMed](pubs.acs.org/ACSNanoMed)  Review   \nNanotechnology in Cancer Therapy: How Nanoparticles Are Shaping the Future of Personalized Treatment  \nIndrianita Lionadi and Amir Farokh Payam *  \n Cite This: ACS Nano Med. 2026, 1, 871−911  \nRead Online  \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |\n\nABSTRACT: Nanotechnology has transformed cancer research, with nanoparticles emerging as powerful platforms for therapy and diagnosis due to their tunable physicochemical properties and biocompatibility. Nanoparticles enable targeted drug delivery, improved pharmacokinetics, and reduced systemic toxicity compared with conventional therapies while also supporting molecular imaging and theragnostic applications. More than eight nanoparticle-based formulations are currently FDA/EMA approved for oncology, highlighting the clinical relevance of nanomedicine. Despite these advances, clinical translation remains limited by biological and technical challenges, including variability in the enhanced permeability and retention effect, insufficient tumor penetration, and low manufacturing scalability. This review  \nprimarily focuses on preclinical and translational nanomedicine with selected clinical examples. We summarize recent progress in major nanocarrier classes, including liposomes and polymeric, inorganic, and hybrid nanoparticles, and their roles in cancer therapy. These findings underscore that effective nanotherapeutic strategies must be informed by tumor biology rather than relying on passive targeting alone, that combination and stimuli-responsive platforms represent the most promising therapeutic avenues, and that meaningful clinical translation will depend on overcoming tumor heterogeneity with patient-specific treatment options and achieving robust, reproducible manufacturing.  \nKEYWORDS: cancer nanomedicine, targeted drug delivery, nanoparticle-based therapeutics, clinical translation challenges, combination therapies  \n1. INTRODUCTION  \nThe emergence of nanotechnology has catalyzed significant advancements across a wide array of scientific and technological disciplines, laying the groundwork for transformative innovations that continue to impact human health and wellbeing. At the heart of this revolution are nanoparticles (NPs), fundamental building blocks ofthe nanoscale world. These tiny structures operate at the interface of disciplines, enabling  \napplications that span from medicine to materials science. 1  \nIn the field of medicine, nanoparticles have become pivotal due to their precision, biocompatibility, and functional versatility.2 They play a crucial role in targeted drug delivery, enabling therapeutic agents to reach specific cells or tissues with remarkable accuracy, thereby minimizing side effects and enhancing therapeutic outcomes.1 Moreover, their capacity to carry contrast agents or fluorescent dyes has opened new frontiers in molecular imaging, facilitating early disease detection and improved diagnostics.3 The excitement surrounding nanoparticles stems from their tunable physicochemical properties, high surface-to-volume ratio, and ability to be surface-functionalized, making them ideal for  \nthe development of novel biomaterials, biosensors, and nanodevices in medical and biological contexts.4  \nIn healthcare technologies, nanoparticle applications can be broadly divided into two major sectors: (i) the design of advanced biomaterials,5 and (ii) the development of biosensors, diagnostic platforms, and drug delivery systems.6,7 Despite valid public concerns and ongoing investigations into nanotoxicity mechanisms,8 research in this area remains highly active and promising.  \nCancer represents a major and escalating global health burden that has persisted for decades. It is one of the leading causes of mortality worldwide, accounting for nearly 10 million deaths annually􀀁approximately one in six dea","cbCaiu33a65wppUC","https://ap.wps.com/l/cbCaiu33a65wppUC","pdf",3447062,41,"English","# Abstract\n# Keywords\n# 1. INTRODUCTION\n## Nanoparticles in medicine and healthcare technologies\n## Cancer burden and motivation for nanotherapy","[{\"question\":\"What advantages do nanoparticles provide for cancer therapy and diagnosis?\",\"answer\":\"Nanoparticles offer tunable physicochemical properties and biocompatibility, enabling targeted drug delivery, better pharmacokinetics, and reduced systemic toxicity. They also support molecular imaging and theragnostic applications such as imaging-guided therapy.\"},{\"question\":\"Why is clinical translation of nanomedicine still limited?\",\"answer\":\"Clinical translation is constrained by biological and technical challenges including variability in the enhanced permeability and retention (EPR) effect, insufficient tumor penetration, and low manufacturing scalability.\"},{\"question\":\"How does this review structure its discussion of nanoparticle approaches?\",\"answer\":\"The review emphasizes preclinical and translational nanomedicine with selected clinical examples. It summarizes progress across major nanocarrier classes, including liposomes and polymeric, inorganic, and hybrid nanoparticles, and discusses their roles in cancer therapy.\"}]","Nanotechnology in Cancer Therapy - How Nanoparticles Are Shaping the Future of Personalized Treatment | PDF",1790151098,103,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7b37b0f963d3ad7bdfa594af96ae495.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fac5108d924a43581edeadc1f20ef1c.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/129cf85fa63d5050cf26377f42346d71.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2540f4d449f4e06f1f4466c152dbf074.webp",980,1292,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e53ca98f0b3f66cd66f4e41bc138f4e5.webp",979,1291]